Summary In 2010, modified RECIST (mRECIST) criteria were proposed as a way of
adapting the RECIST criteria to the particularities of hepatocellular carcinoma (HCC). We …

Receptor tyrosine kinases (RTKs) are key regulatory signaling proteins governing cancer
cell growth and metastasis. During the last two decades, several molecules targeting RTKs …

Background All randomised phase 3 studies of selective internal radiation therapy for
advanced hepatocellular carcinoma published to date have reported negative results …

Primary liver cancer, the major histology of which is hepatocellular carcinoma (HCC), is the
second leading cause of cancer death worldwide. We comprehensively examined recent …

Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Hepatocellular carcinoma (HCC) commonly emerges in an immunologically “cold” state,
thereafter protects it away from cytolytic attack by tumor‐infiltrating lymphocytes, resulting in …

Hepatocellular carcinoma (HCC) is the most frequent liver cancer with high lethality and low
five-year survival rates leading to a substantial worldwide burden for healthcare systems …

Purpose To compare the efficacy and safety of combined treatment with lenvatinib and
transarterial chemoembolization (TACE) versus TACE only in patients with unresectable …

Objective: To compare the short-and long-term outcomes of robot-assisted (RALR),
laparoscopic (LLR), or open liver resection (OLR) in the treatment of Barcelona Clinic Liver …

Hepatocellular carcinoma (HCC) is the second deadliest cancer worldwide, due to its high
incidence and poor prognosis. Frequent initial presentation at advanced stages along with …